Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
Tfrc
REST API REST API
Mus musculus
Tfrc is differentially expressed in 327 experiments: 125 organism parts: liver, hippocampus, ... (123 more);, 25 disease states: normal, reference, ... (23 more);, 87 cell types 23 cell lines 55 compound treatments and 38 other conditions.
Synonyms 'Trfr', 'CD71', 'Mtvr-1', 'TfR1', 'Mtvr1', 'p90'
Orthologs TFRC (Gallus gallus)   TFRC (Bos taurus)   TFRC (Homo sapiens)   VPS70 (Saccharomyces cerevisiae)   Tfrc (Rattus norvegicus)   tfrc (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term plasma membrane, response to copper ion, Hsp70 protein binding, iron ion transmembrane transporter activity, acute-phase response, membrane, peptidase activity, chaperone binding, extracellular region, response to hypoxia, response to nutrient, coated pit, aging, receptor activity, cytoplasmic membrane-bounded vesicle, endosome, perinuclear region of cytoplasm, proteolysis, integral to membrane, cellular iron ion homeostasis, cell surface, mitochondrion, endocytosis, extracellular vesicular exosome, recycling endosome membrane, response to iron ion, positive regulation of bone resorption, transferrin receptor activity, iron ion transmembrane transport, response to retinoic acid, response to inorganic substance, response to organic substance, response to manganese ion, melanosome, osteoclast differentiation
InterPro Term Peptidase_M28, Protease-assoc_domain, TFR-like_dimer_dom
Search EB-eye ENSMUSG00000022797
Show more properties
Experimental Factors
Organism part

studied in E-TABM-1039, E-GEOD-1479, E-GEOD-20160, E-GEOD-3963, E-GEOD-2866, ... (65 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-21515, E-GEOD-19732, E-GEOD-1956, E-GEOD-10246, E-MEXP-2554, ... (8 experiments)

Factor Value U/D Experiments
B117H
2
1
E-GEOD-18322
N1E-115 Tcof1 overexpressed
1
E-GEOD-1956
1
1
E-GEOD-10246
IP20D-3
1
E-GEOD-21515
R1
1
E-GEOD-21515
Swiss22
1
E-GEOD-19732
17 more value(s).


Cell type

studied in E-GEOD-2585, E-GEOD-7069, E-GEOD-7764, E-GEOD-21749, E-GEOD-829, ... (31 experiments)

Factor Value U/D Experiments
hematopoietic stem cell
1
3
E-GEOD-7069, E-GEOD-20377, E-GEOD-6623, E-MEXP-1158
laminin binding germ cell
1
E-GEOD-829
CD45+
1
1
E-GEOD-2057
CD45-
1
1
E-GEOD-2057
CD80 low medullary thymic epithelial cell
1
1
E-GEOD-2585
cornea
1
E-GEOD-10246
81 more value(s).


Disease state

studied in E-GEOD-670, E-GEOD-19004, E-GEOD-21927, E-GEOD-2514, E-GEOD-1871, ... (16 experiments)

Factor Value U/D Experiments
reference
2
E-GEOD-1871, E-MEXP-1755
growth suppression
1
E-MEXP-835
breast carcinoma
1
1
E-GEOD-2528
dystrophic
1
E-MEXP-1623
heart failure
1
E-GEOD-670
type 2 diabetes
1
E-GEOD-642
19 more value(s).


Compound treatment

studied in E-GEOD-19684, E-GEOD-21711, E-GEOD-6085, E-TABM-903, E-GEOD-1301, ... (37 experiments)

Factor Value U/D Experiments
none
4
8
E-MEXP-1237, E-GEOD-6376, E-GEOD-5304, E-GEOD-2973, E-MEXP-1137, ... (12 experiments)
control
3
6
E-GEOD-21710, E-GEOD-21361, E-TABM-903, E-GEOD-4671, E-GEOD-469, ... (9 experiments)
cardiotoxin
3
E-GEOD-5304, E-GEOD-469, E-MEXP-703
vehicle - arachis oil
2
E-GEOD-1839, E-GEOD-2195
trichostatin A and dipyridyl
1
E-GEOD-3296
pentachloronitrobenzene
1
E-GEOD-5128
49 more value(s).


Agent

studied in E-GEOD-32706

Factor Value U/D Experiments
control
1
1
E-GEOD-32706
fenofibrate
1
1
E-GEOD-32706


Amount to core
studied in E-GEOD-18858

Bioanalyzer results
studied in E-GEOD-18858

cell population
studied in E-GEOD-26086

Clinical info
studied in E-MEXP-1458, E-GEOD-1800, E-GEOD-2127

Cohort
studied in E-GEOD-20524, E-GEOD-4356

Developmental stage
studied in E-GEOD-1026, E-GEOD-1867, E-GEOD-8191, E-GEOD-989, E-GEOD-1947, ... (33 experiments)

dose or concentration
studied in E-GEOD-18858

Family history
studied in E-GEOD-19194

Fraction
studied in E-TABM-363

Genetic modification
studied in E-GEOD-2188, E-GEOD-3172

Genotype
studied in E-GEOD-19684, E-GEOD-19004, E-GEOD-7020, E-GEOD-2746, E-TABM-285, ... (47 experiments)

Growth condition
studied in E-GEOD-1867, E-GEOD-3889, E-GEOD-934, E-GEOD-4310, E-MEXP-1649, ... (10 experiments)

Histology
studied in E-GEOD-15904

in vivo treatment
studied in E-GEOD-18858

Infection
studied in E-GEOD-17049, E-GEOD-4324, E-GEOD-6688, E-MEXP-1717, E-GEOD-20302, ... (6 experiments)

infection duration (days)
studied in E-GEOD-20524

infection status
studied in E-GEOD-20524

Injury
studied in E-GEOD-1999, E-GEOD-5296

Light
studied in E-TABM-285

Media
studied in E-MEXP-718

Observation
studied in E-GEOD-3594, E-GEOD-5296

Od260
studied in E-GEOD-18858

Organism
studied in E-MEXP-667

Phenotype
studied in E-GEOD-272, E-GEOD-15840

Protocol type
studied in E-GEOD-12293, E-GEOD-21389, E-GEOD-16192

Replicate
studied in E-GEOD-17112

Rna integrity number
studied in E-GEOD-18858

sample preservation
studied in E-GEOD-18858

Sex
studied in E-GEOD-75, E-GEOD-97, E-MEXP-1711, E-TABM-412

Stimulus or stress
studied in E-GEOD-15894, E-GEOD-15902, E-GEOD-15901

Strain or line
studied in E-TABM-865, E-GEOD-21515, E-GEOD-16994, E-TABM-562, E-MTAB-76, ... (15 experiments)

Treatment
studied in E-MTAB-76, E-GEOD-21902, E-GEOD-18344, E-GEOD-21841, E-GEOD-21546, ... (10 experiments)

Treatment repeat
studied in E-GEOD-18858

Treatment time
studied in E-GEOD-18858

Units of amount
studied in E-GEOD-18858

Units of amount of vehicle
studied in E-GEOD-18858

vehicle for chemical
studied in E-GEOD-18858

Processing time: 0.193 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM